(Q84382888)

English

Pixantrone dimaleate in combination with fludarabine, dexamethasone, and rituximab in patients with relapsed or refractory indolent non-Hodgkin lymphoma: phase 1 study with a dose-expansion cohort

scientific article published on 16 June 2011

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21681734%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Pixantrone dimaleate in combination with fludarabine, dexamethasone, and rituximab in patients with relapsed or refractory indolent non-Hodgkin lymphoma: phase 1 study with a dose-expansion cohort (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21681734%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

non-Hodgkin lymphoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21681734%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

9

object named as

Luis E Fayad

0 references

author name string

Tomasz P Srokowski

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21681734%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

James E Liebmann

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21681734%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Manuel R Modiano

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21681734%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Gary I Cohen

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21681734%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Barbara Pro

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21681734%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Jorge E Romaguera

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21681734%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Christine Kuepfer

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21681734%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

publication date

16 June 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21681734%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21681734%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

117

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21681734%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

22

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21681734%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

5067-5073

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21681734%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

In vitro evaluation of acute effects of mitoxantrone (Novantrone) in rat and guinea pig atria

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26121

7 January 2021

based on heuristic

inferred from DOI database lookup

Late cardiac toxicity of doxorubicin, epirubicin, and mitoxantrone therapy for Hodgkin's disease in adults

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26121

7 January 2021

based on heuristic

inferred from DOI database lookup

6,9-Bis[(aminoalkyl)amino]benzo[g]isoquinoline-5,10-diones. A novel class of chromophore-modified antitumor anthracene-9,10-diones: synthesis and antitumor evaluations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26121

7 January 2021

based on heuristic

inferred from DOI database lookup

Bbr 2778, an aza-anthracenedione endowed with preclinical anticancer activity and lack of delayed cardiotoxicity.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26121

7 January 2021

based on heuristic

inferred from DOI database lookup

Pixantrone (BBR 2778) has reduced cardiotoxic potential in mice pretreated with doxorubicin: comparative studies against doxorubicin and mitoxantrone.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26121

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I study of BBR 2778, a new aza-anthracenedione, in advanced or refractory non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26121

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase I/II trial of pixantrone (BBR2778), methylprednisolone, cisplatin, and cytosine arabinoside (PSHAP) in relapsed/refractory aggressive non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26121

7 January 2021

based on heuristic

inferred from DOI database lookup

Pixantrone maleate for non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26121

7 January 2021

based on heuristic

inferred from DOI database lookup

Update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based clinical practice guidelines. American Society of Clinical Oncology

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26121

7 January 2021

based on heuristic

inferred from DOI database lookup

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26121

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I study of the combination of fludarabine, mitoxantrone, and dexamethasone in low-grade lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26121

7 January 2021

based on heuristic

inferred from DOI database lookup

Fludarabine, mitoxantrone, and dexamethasone: an effective new regimen for indolent lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26121

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.26121

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21681734%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21681734%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q84382888&oldid=2035043624"